Treatment of Alzheimer’s

Technical Description The present invention provides the synthesis of novel quinolinyl piperazine derivatives for the treatment of Alzheimer’s disease by dual inhibition of β-secretase (BACE1) and acetylcholineesterase (AChE). Problems Addressed Aβ Accumulation in Brain Single Target Therapy Current Treatment Limitations…








